Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Jacobs

Showing results (571-580 of 590) with videos related to

Pageof 59
Sort By:
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
Applied Optics|March 13, 2013
Improving the performance of high-laser-damage-threshold, multilayer dielectric pulse-compression gratings through low-temperature chemical cleaningHeather P Howard, Anthony F Aiello, Justin G Dressler, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Annals of Neurology|December 16, 2000
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research GroupJ S Fischer, R L Priore, L D Jacobs, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Soft tissue sarcomaGeorge D Demetri, Laurence H Baker, Robert S Benjamin, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Pageof 59

Showing results (571-580 of 590) with videos related to

Sort By:
Pageof 59
Cancer|October 4, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical careLisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland, et al.
Applied Optics|March 13, 2013
Improving the performance of high-laser-damage-threshold, multilayer dielectric pulse-compression gratings through low-temperature chemical cleaningHeather P Howard, Anthony F Aiello, Justin G Dressler, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of InfluenzaUpul K Bandarage, Michael P Clark, Emanuele Perola, et al.
Neurology|July 26, 2000
A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a. Multiple Sclerosis Collaborative Research GroupJ H Simon, J Lull, L D Jacobs, et al.
Annals of Neurology|December 16, 2000
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research GroupJ S Fischer, R L Priore, L D Jacobs, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 20, 2007
Soft tissue sarcomaGeorge D Demetri, Laurence H Baker, Robert S Benjamin, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis ConsortiumB Weinstock-Guttman, L D Jacobs, C M Brownscheidle, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Pageof 59